Methyl 2,3-dioxoindoline-4-carboxylate, 97%, 100mg

(3aR,3a'R,8aS,8a'S)-2,2'-(1,3-Diphenylpropane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole), 98.0%, 1g

tert-Butyl 3-aminopropanoate hydrochloride, 97.0%, 10g

2-(4-METHYLTHIAZOL-5-YL)ETHYL HEXANOATE, 95%, 5g

Silizium(IV)-nitrid 100 g

(1R)-1-Cyclobutylethan-1-amine hydrochloride, 98%, 100mg

6,7-Difluoro-1H-indazole, 95.0%, 5g

1-Methoxy-3-[(E)-2-nitrovinyl]benzene, 97.0%, 5g

Rotilabo®-Gewindefläschchen ND13, 4 ml, Klarglas, mit Beschriftungsfeld, 100 Stück

4-Amino-N,N-dimethylbenzylamine, 95.0%, 100g

2-(2,2-dimethylpropanamido)-4-methylpentanoic acid, 97%, 1g

2-Methylimidazo[1,2-a]pyrimidine-3-carboxylic acid, 95.0%, 1g

1-(2-Chlorobenzyl)-3,5-dimethyl-1H-pyrazole-4-carboxylic acid, >95%, 250mg